p.127 抽出テキスト

32: 820-826. PMID: 5212356 82. Murphy JG, Gersh BJ, McGoon MD, et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med 1990; 323: 1645-1650. PMID: 2233961 83. Nakagawa K, Akagi T, Taniguchi M, et al. Transcatheter closure of atrial septal defect in a geriatric population. Catheter Cardiovasc Interv 2012; 80: 84-90. PMID: 22234992 84. Akagi T. Catheter intervention for adult patients with congenital heart disease. J Cardiol 2012; 60: 151-159. PMID: 22890075 85. Takaya Y, Taniguchi M, Akagi T, et al. Long-term effects of transcatheter closure of atrial septal defect on cardiac remodeling and exercise capacity in patients older than 40 years with a reduction in cardiopulmonary function. J Interv Cardiol 2013; 26: 195-199. PMID: 23163398 86. Shah AH, Osten M, Leventhal A, et al. Percutaneous Intervention to Treat Platypnea-Orthodeoxia Syndrome: The Toronto Experience. JACC Cardiovasc Interv 2016; 9: 1928-1938. PMID: 27659570 87. Takaya Y, Akagi T, Kijima Y, et al. Transcatheter closure of right-toleft atrial shunt in patients with platypnea-orthodeoxia syndrome associated with aortic elongation. Cardiovasc Interv Ther 2014; 29: 221-225. PMID: 24481499 88. Watanabe N, Taniguchi M, Akagi T, et al. Usefulness of the right parasternal approach to evaluate the morphology of atrial septal defect for transcatheter closure using two-dimensional and three-dimensional transthoracic echocardiography. J Am Soc Echocardiogr 2012; 25: 376-382. PMID: 22285413 89. Taniguchi M, Akagi T, Kijima Y, et al. Clinical advantage of real-time three-dimensional transesophageal echocardiography for transcatheter closure of multiple atrial septal defects. Int J Cardiovasc Imaging 2013; 29: 1273-1280. PMID: 23609549 90. Osawa K, Miyoshi T, Morimitsu Y, et al. Comprehensive assessment of morphology and severity of atrial septal defects in adults by CT. J Cardiovasc Comput Tomogr 2015; 9: 354-361. PMID: 26088383 91. Schoen SP, Kittner T, Bohl S, et al. Transcatheter closure of atrial septal defects improves right ventricular volume, mass, function, pulmonary pressure, and functional class: a magnetic resonance imaging study. Heart 2006; 92: 821-826. PMID: 16284222 92. Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2915-2957. PMID: 20801927 93. Chessa M, Baumgartner H, Michel-Behnke I, et al. ESC Working Group Position Paper: Transcatheter adult congenital heart disease interventions: organization of care – recommendations from a Joint Working Group of the European Society of Cardiology (ESC), European Association of Pediatric and Congenital Cardiology (AEPC), and the European Association of Percutaneous Cardiac Intervention (EAPCI). Eur Heart J 2019; 40: 1043-1048. PMID: 30376060 94. Kijima Y, Akagi T, Takaya Y, et al. Treat and Repair Strategy in Patients With Atrial Septal Defect and Significant Pulmonary Arterial Hypertension. Circ J 2016; 80: 227-234. PMID: 26567484 95. Zwijnenburg RD, Baggen VJM, Witsenburg M, et al. Risk Factors for Pulmonary Hypertension in Adults After Atrial Septal Defect Closure. Am J Cardiol 2019; 123: 1336-1342. PMID: 30709596 96. Brida M, Diller GP, Nashat H, et al. Pharmacological therapy in adult congenital heart disease: growing need, yet limited evidence. Eur Heart J 2019; 40: 1049-1056. PMID: 30137263 97. 日本循環器学会.肺高血圧症治療ガイドライン(2017年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2017_ fukuda_h.pdf 98. Takaya Y, Akagi T, Kijima Y, et al. Functional Tricuspid Regurgitation After Transcatheter Closure of Atrial Septal Defect in Adult Patients: Long-Term Follow-Up. JACC Cardiovasc Interv 2017; 10: 2211-2218. PMID: 29055761 99. Takaya Y, Kijima Y, Akagi T, et al. Fate of Mitral Regurgitation After Transcatheter Closure of Atrial Septal Defect in Adults. Am J Cardiol 2015; 116: 458-462. PMID: 26026868 100. Yamaoka H, Takaya Y, Watanabe N, et al. Infective Endocarditis of Patent Foramen Ovale Closure Device Presenting as an Amoeboid-Like Mass. JACC Cardiovasc Interv 2018; 11: 2337-2338. PMID: 30391388 101. Takaya Y, Akagi T, Kijima Y, et al. Long-term outcome after transcatheter closure of atrial septal defect in older patients: impact of age at procedure. JACC Cardiovasc Interv 2015; 8: 600-606. PMID: 25907086 102. Crandall MA, Daoud EG, Daniels CJ, et al. Percutaneous radiofrequency catheter ablation for atrial fibrillation prior to atrial septal defect closure. J Cardiovasc Electrophysiol 2012; 23: 102-104. PMID: 21914020 103. Fujii Y, Akagi T, Nakagawa K, et al. Clinical impact of transcatheter atrial septal defect closure on new onset atrial fibrillation in adult patients: Comparison with surgical closure. J Cardiol 2020; 76: 94-99. PMID: 32098750 104. Nakagawa K, Akagi T, Nagase S, et al. Efficacy of catheter ablation for paroxysmal atrial fibrillation in patients with atrial septal defect: a comparison with transcatheter closure alone. Europace 2019; 21: 1663-1669. PMID: 31410454 105. Taniguchi M, Akagi T, Ohtsuki S, et al. Transcatheter closure of atrial septal defect in elderly patients with permanent atrial fibrillation. Catheter Cardiovasc Interv 2009; 73: 682-686. PMID: 19133674 106. Suda K, Raboisson MJ, Piette E, et al. Reversible atrioventricular block associated with closure of atrial septal defects using the Amplatzer device. J Am Coll Cardiol 2004; 43: 1677-1682. PMID: 15120830 107. Lemler MS, Scott WA, Leonard SR, et al. Fenestration improves clinical outcome of the fontan procedure: a prospective, randomized study. Circulation 2002; 105: 207-212. PMID: 11790702 108. Kopf GS, Kleinman CS, Hijazi ZM, et al. Fenestrated Fontan operation with delayed transcatheter closure of atrial septal defect. Improved results in high-risk patients. J Thorac Cardiovasc Surg 1992; 103: 1039-1048. PMID: 1597968 109. Takeda M, Shimada M, Sekiguchi A, et al. Long-term results of the fenestrated Fontan operation. Progress of patients with patent fenestrations. Jpn J Thorac Cardiovasc Surg 1999; 47: 432-439. PMID: 10513137 110. Kim SJ, Kim WH, Lim HG, et al. Outcome of 200 patients after an extracardiac Fontan procedure. J Thorac Cardiovasc Surg 2008; 136: 108-116. PMID: 18603062 111. Fan F, Liu Z, Li S, et al. Effect of Fenestration on Early Postoperative Outcome in Extracardiac Fontan Patients with Different Risk Levels. Pediatr Cardiol 2017; 38: 643-649. PMID: 28116475 112. Sommer RJ, Recto M, Golinko RJ, et al. Transcatheter coil occlusion of surgical fenestration after Fontan operation. Circulation 1996; 94: 249-252. PMID: 8759062 113. Cowley CG, Badran S, Gaffney D, et al. Transcatheter closure of fontan fenestrations using the Amplatzer septal occluder: initial experience and follow-up. Catheter Cardiovasc Interv 2000; 51: 301-304. PMID: 11066111 114. Marini D, Boudjemline Y, Agnoletti G. Closure of extracardiac Fontan fenestration by using the covered Cheatham Platinum stent. Catheter Cardiovasc Interv 2007; 69: 1002-1006. PMID: 17492790 115. Ebeid MR, Mehta I, Gaymes CH. Closure of external tunnel Fontan fenestration: a novel use of the Amplatzer vascular plug. Pediatr Cardiol 2009; 30: 15-19. PMID: 18712435 116. Gundel F, Liebig T, Eicken A, et al. Electrolytically detachable coils for closure of a modified baffle fenestration in patients with hypoplastic left heart syndrome (HLHS). Int J Cardiol 2009; 135: e49-e51. PMID: 18603319 117. McCrossan BA, Walsh KP. Fontan fenestration closure with Amplatzer Duct Occluder II device. Catheter Cardiovasc Interv 2015; 85: 837-841. PMID: 25504151 118. Goff DA, Blume ED, Gauvreau K, et al. Clinical outcome of fenestrated Fontan patients after closure: the first 10 years. Circulation 2000; 102: 2094-2099. PMID: 11044426 119. Pihkala J, Yazaki S, Mehta R, et al. Feasibility and clinical impact of transcatheter closure of interatrial communications after a fenestrated Fontan procedure: medium-term outcomes. Catheter Cardiovasc Interv 2007; 69: 1007-1014. PMID: 17421018 120. Momenah TS, Eltayb H, Oakley RE, et al. Effects of transcatheter closure of Fontan fenestration on exercise tolerance. Pediatr Cardiol 2008; 29: 585-588. PMID: 18071783 121. Mays WA, Border WL, Knecht SK, et al. Exercise capacity improves after transcatheter closure of the Fontan fenestration in children. Congenit Heart Dis 2008; 3: 254-261. PMID: 18715459 122. Meadows J, Lang P, Marx G, et al. Fontan fenestration closure has no acute effect on exercise capacity but improves ventilatory response to exercise. J Am Coll Cardiol 2008; 52: 108-113. PMID: 18598888 123. Kotani Y, Chetan D, Saedi A, et al. Persistent fenestration may be a marker for physiologic intolerance after Fontan completion. J Thorac Cardiovasc Surg 2014; 148: 2532-2538. PMID: 25135233 124. Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019; 73: e81-e192. PMID: 30121239 125. Haas NA, Kock L, Bertram H, et al. Interventional VSD-Closure with the Nit-Occlud® Lê VSD-Coil in 110 Patients: Early and Midterm Results of the EUREVECO-Registry. Pediatr Cardiol 2017; 38: 215- 227. PMID: 27847970